A veteran biostatistician on the planning document and the dose-selection shortcut that quietly decide whether trials succeed.
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Patient Diversity Case Study: RWD Solutions
See how by leveraging medical claims and diversity data, this clinical trial sponsor was able to identify relevant patients meeting the trial’s I/E criteria, broken out by race and gender.
-
Why Open API Architecture Matters In Clinical Research
Clinical trials need flexible workflows, but layered integrations add complexity. Open APIs enable real-time data exchange so processes adapt without fragile dependencies or added overhead.
-
5 Best Practices For Getting Started With ePRO
Unlock the potential of electronic Patient Reported Outcomes (ePRO) in your clinical research by implementing these essential best practices for success.
-
Unified Patient Apps: The Future Of Trial Simplicity
A unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments—reducing burden, improving engagement, and supporting better retention and data quality.
-
5 Trends To Watch This Year
Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.
-
Early-Stage Biotech's AI Advantage Is A Window That Closes
FDA AI guidance won’t build your strategy for you. Learn how biotech teams can avoid retrofits and design smarter clinical AI from day one.
-
Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases
Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.
-
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them
Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
5 Features to Look for in Your Next eTMF
Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.
-
5 Ways Lab Data Can Help Commercialize Your Therapy
Delve into five pivotal insights for leveraging lab data effectively and the collaboration that accelerated market entry for new therapies while ensuring the needs of targeted populations were met.
RECENT NEWSLETTERS
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build